NKTX vs MTAC
Comparison between Nkarta Inc (NKTX, Company) and MedTech Acquisition Corp - Class A (MTAC, Company).
NKTX vs MTAC - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
NKTX
$183M
Winner
MTAC
$183M
Max Drawdown
NKTX
98.27%
Winner
MTAC
13.92%
Sharpe Ratio
Winner
NKTX
0.80
MTAC
0.44
5Y Beta
NKTX
1.36
MTAC
N/A
Industry
NKTX
Biotechnology
MTAC
N/A
P/E Ratio
NKTX
-1.74
Winner
MTAC
-32.94
Debt to Equity
NKTX
0.00%
MTAC
0.00%
Free Cash Flow Yield
NKTX
-48.39%
Winner
MTAC
-27.91%
P/S Ratio
NKTX
1000000.00
Winner
MTAC
12.43
P/B Ratio
NKTX
0.62
Winner
MTAC
-12.13
NKTX vs MTAC - Historical Returns
Returns include dividend reinvestment.
1M
NKTX
-12.80%
Winner
MTAC
+7.90%
3M
Winner
NKTX
+24.89%
MTAC
+9.99%
6M
Winner
NKTX
+52.13%
MTAC
+11.55%
1Y
Winner
NKTX
+49.74%
MTAC
+14.55%
5Y(CAGR)
NKTX
-35.19%
MTAC
N/A
Max(CAGR)
NKTX
-37.87%
Winner
MTAC
+3.05%
NKTX vs MTAC - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | NKTX | MTAC |
|---|---|---|
| 2026 | +52.94% | N/A |
| 2025 | -26.00% | N/A |
| 2024 | -60.91% | N/A |
| 2023 | +9.45% | +12.84% |
| 2022 | -60.04% | +0.80% |
| 2021 | -74.25% | -6.08% |
| 2020 | +28.33% | N/A |
NKTX vs MTAC Drawdown Comparison
The maximum drawdown for NKTX was -98.27%, occurring on Oct 2, 2023. This drawdown has not yet recovered.
The maximum drawdown for MTAC was -13.92%, occurring on Mar 7, 2022. Recovery took 622 trading sessions.
The current NKTX drawdown is -96.22%.
| Rank | NKTX | MTAC |
|---|---|---|
| #1 | -98.27% Dec 23, 2020 - Oct 2, 2023 | -13.92% Feb 19, 2021 - Aug 10, 2023 |
| #2 | -50.90% Jul 10, 2020 - Dec 7, 2020 | -1.90% Feb 8, 2021 - Feb 16, 2021 |
| #3 | -12.82% Dec 10, 2020 - Dec 22, 2020 | N/A |
Correlation
Correlation between NKTX and MTAC is -0.42 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
-0.42
-101
Select Stocks to Compare
Popular: NKTX vs SPYMTAC vs SPY
More Comparisons
Compare with similar stocks